ELEV Elevation Oncology Inc.: Accounting Value per Share

Public company logo of Elevation Oncology Inc. (ELEV)

Can Elevation Oncology (ELEV) develop breakthrough ADC drugs for solid tumors? This bvps chart provides the answer, while the 0.79 metric confirms the current capital level. However, intense competition and a shortage of funds create significant risks. Patents for targeted therapy and work with rare cancer biomarkers support the business stability.

elevationoncology.com (ELEV) - Accounting Value per Share from 07/04/2022 to 08/02/2025

Summary analytical data breakdowns for elevationoncology.com (ELEV)

- price and consensus price forecast:
Stock Price Elevation Oncology|ELEV - Average Forecast Price
- market capitalization data:
Market Valuation Elevation Oncology, Inc.|ELEV - Total Company Value
- book capitalization data:
Book Value per Share Elevation Oncology|ELEV - Company Net Assets|Market Capitalization to Book Value Ratio elevationoncology.com|ELEV - Company Total Assets
- debt and liquidity data:
Debt to Equity Elevation Oncology|ELEV - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Elevation Oncology, Inc.|ELEV - Company Total Debt|Debts to Book Capitalization Elevation Oncology, Inc.
Analysis of all company metrics:Elevation Oncology, ELEV
Manufactured product of elevationoncology.com

Book value per share is calculated as the difference between all company assets and liabilities divided by the number of outstanding shares, reflecting the actual value of a single holding in the event of business liquidation. For Elevation Oncology (ELEV), which operates in the macro-independent innovative medicine sector, the book value trend of the common share confirms the effectiveness of capital accumulation driven by stable demand for its developments.

Competitor analysis for Elevation Oncology

ONC (BeiGene Corp) - Book Value per Share|Halozyme Corp (HALO) - Net Asset Value per Share|Revolution Medicines (RVMD) - Accounting Value per Share|ascentage.com (AAPG) - Net Assets per Single Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Accounting Value per Share|Accounting Value of a Share tuhurabio.com (HURA)|Protara - Book Value per Share|FATE - Accounting Value per Share|Aadi Bio - Accounting Value per Share|TCRX: Book Value per Share|Net Assets per Single Share championsoncology.com CSBR|XBiotech (XBIT) - Accounting Value of a Share|Book Value per Share CVM (CEL-SCI Corp.)|Net Asset Value per Share OS Therapies, Inc.|Radiopharm Theranostics Limited - Book Value per Share|Net Asset Value per Share ARTV (artivabio.com)|Net Assets per Single Share Adlai Nortye ANL|Net Assets per Single Share Veru Inc VERU|TPST (Tempest Tx) - Book Value per Share|Xilio Therapeutics, Inc. (XLO) - Net Asset Value per Share|renovarobio.com (RENB) - Accounting Value per Share|Mural Oncology (MURA) - Net Assets per Single Share|KAPA (Kairos Pharma Limited) - Book Value per Share|Book Value per Share OnKure (OKUR)|Accounting Value per Share CytoMed Therapeutics|Book Price of a Share curis.com (CRIS)|Book Value per Share APLM|tharimmune.com - Net Assets per Share|ADVB (Advanced Biomed Corp) - Net Assets per Single Share|GNPX: Net Asset Value per Share|Net Assets per Single Share calidibio.com|Equity per Share Sunshine Biopharma Inc.|XBIO - Accounting Value per Share|Accounting Value of a Share SLRX|Purple Biotech Ltd. - Net Assets per Single Share|Net Asset Value per Share AONC (aoncology.com)|BGNE - Net Assets per Single Share|Equity per Share Checkpoint Therapeutics Inc CKPT|ICAD: Book Value per Share|IKNA: Accounting Value per Share|Net Assets per Single Share NTBL|VIRX (Viracta Therapeutics, Inc.) - Net Asset Value per Share|Net Assets per Single Share MorphoSys Corp|Net Assets per Single Share NAYA|Ascentage Pharma Group - Net Assets per Single Share